Standard
Combination of biomarkers : PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment. / Thurfjell, Lennart; Lötjönen, Jyrki; Lundqvist, Roger; Koikkalainen, Juha; Soininen, Hilkka; Waldemar, Gunhild; Brooks, David; Vandenberghe, Rik.
I:
Neurodegenerative Diseases, Bind 10, Nr. 1-4, 2012, s. 246-9.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Thurfjell, L, Lötjönen, J, Lundqvist, R, Koikkalainen, J, Soininen, H
, Waldemar, G, Brooks, D & Vandenberghe, R 2012, '
Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment',
Neurodegenerative Diseases, bind 10, nr. 1-4, s. 246-9.
https://doi.org/10.1159/000335381APA
Thurfjell, L., Lötjönen, J., Lundqvist, R., Koikkalainen, J., Soininen, H.
, Waldemar, G., Brooks, D., & Vandenberghe, R. (2012).
Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment.
Neurodegenerative Diseases,
10(1-4), 246-9.
https://doi.org/10.1159/000335381Vancouver
Thurfjell L, Lötjönen J, Lundqvist R, Koikkalainen J, Soininen H
, Waldemar G o.a.
Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment.
Neurodegenerative Diseases. 2012;10(1-4):246-9.
https://doi.org/10.1159/000335381Author
Thurfjell, Lennart ; Lötjönen, Jyrki ; Lundqvist, Roger ; Koikkalainen, Juha ; Soininen, Hilkka ; Waldemar, Gunhild ; Brooks, David ; Vandenberghe, Rik. / Combination of biomarkers : PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment. I: Neurodegenerative Diseases. 2012 ; Bind 10, Nr. 1-4. s. 246-9.
Bibtex
@article{73cdc07bf47c40f0a9d6a874b02ded2e,
title = "Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment",
abstract = "The New National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease (AD) incorporate biomarkers in the diagnostic criteria and suggest division of biomarkers into two categories: Aβ accumulation and neuronal degeneration or injury.",
author = "Lennart Thurfjell and Jyrki L{\"o}tj{\"o}nen and Roger Lundqvist and Juha Koikkalainen and Hilkka Soininen and Gunhild Waldemar and David Brooks and Rik Vandenberghe",
note = "Copyright {\textcopyright} 2012 S. Karger AG, Basel.",
year = "2012",
doi = "10.1159/000335381",
language = "English",
volume = "10",
pages = "246--9",
journal = "Neurodegenerative Diseases",
issn = "1660-2854",
publisher = "S Karger AG",
number = "1-4",
}
RIS
TY - JOUR
T1 - Combination of biomarkers
T2 - PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment
AU - Thurfjell, Lennart
AU - Lötjönen, Jyrki
AU - Lundqvist, Roger
AU - Koikkalainen, Juha
AU - Soininen, Hilkka
AU - Waldemar, Gunhild
AU - Brooks, David
AU - Vandenberghe, Rik
N1 - Copyright © 2012 S. Karger AG, Basel.
PY - 2012
Y1 - 2012
N2 - The New National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease (AD) incorporate biomarkers in the diagnostic criteria and suggest division of biomarkers into two categories: Aβ accumulation and neuronal degeneration or injury.
AB - The New National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease (AD) incorporate biomarkers in the diagnostic criteria and suggest division of biomarkers into two categories: Aβ accumulation and neuronal degeneration or injury.
U2 - 10.1159/000335381
DO - 10.1159/000335381
M3 - Journal article
VL - 10
SP - 246
EP - 249
JO - Neurodegenerative Diseases
JF - Neurodegenerative Diseases
SN - 1660-2854
IS - 1-4
ER -
